Korean Circ J.  1975 Dec;5(2):87-92. 10.4070/kcj.1975.5.2.87.

Clinical Experience of Etafenone (Baxacor(R)) in the Treatment of Angina Pectoris

• Choi CH
• Song HS
• Suh SK

• KMID: 2229721
• DOI: http://doi.org/10.4070/kcj.1975.5.2.87

Abstract

The clinical effect of etafenone on 12 cases of angina pectoris(9 males and 3 females with average age of 58.3 years) were studied and following results were obtained: 1. Anginal chest pains were improved after average 9 days (3~15 days) of medication and the dreug was very effective in 41.7%, moderately effective in 33.3% and slightly effective in 25.0% of cases. 2. The ST segment depression of E.C.G. were reduced in 50.0%, improvement of T waves inversion or enlargement of T waves were observed in 66.7% and E.C.G. improvement either ST segment or T wave observed in 75.0% of cases. 3. No side reactions such as hypotension, palpitation, dizziness, headache or gastrointestinal disturbances were seen during the treatement with etafenone.

MeSH Terms

Angina Pectoris*
Chest Pain
Depression
Dizziness
Female
Headache
Humans
Hypotension
Male